Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HGEN

Humanigen (HGEN) Stock Price, News & Analysis

Humanigen logo

About Humanigen Stock (NASDAQ:HGEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.06 million shs
Average Volume
3.26 million shs
Market Capitalization
$24 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humanigen and its competitors with MarketBeat's FREE daily newsletter.

HGEN Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Humanigen, Inc. (HGEN)
0KB1.SG,0P00011RKD,0 (0KB1.SG)
Humanigen Inc (0KB2.BE)
Humanigen Inc HGENQ
See More Headlines

HGEN Stock Analysis - Frequently Asked Questions

Humanigen, Inc. (NASDAQ:HGEN) released its earnings results on Friday, November, 12th. The company reported ($1.12) EPS for the quarter, missing the consensus estimate of ($0.98) by $0.14. The company had revenue of $1.04 million for the quarter, compared to analyst estimates of $0.40 million.

Humanigen's stock reverse split on the morning of Monday, September 14th 2020.The 1-5 reverse split was announced on Friday, September 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humanigen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Pfizer (PFE) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/12/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:HGEN
CIK
1293310
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.70 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.45) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
119,080,000
Free Float
93,240,000
Market Cap
$24 thousand
Optionable
No Data
Beta
-1.04
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:HGEN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners